Chinese herb trial for brain bleed linked to amyloid angiopathy
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a traditional Chinese medicine called Jiedu Huayu to see if it helps people recover from a brain bleed caused by a condition where proteins build up in blood vessel walls (cerebral amyloid angiopathy). The goal is to improve outcomes without surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain bleed in the upper part of your brain that is 40 milliliters or less.
- You started having symptoms within the last 7 days.
- Your doctor thinks it might be caused by a condition called cerebral amyloid angiopathy (protein buildup in brain blood vessels).
- You are between 50 and 90 years old.
- You are alert enough to give consent (GCS score of 8 or higher).
- You have mild to moderate stroke symptoms (NIHSS score 25 or less).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if colchicine can reduce the risk of another stroke caused by bleeding in the brain due to a condition called cerebral amyloid angiopathy (CAA). You may qualify if you've recently had a brain bleed from CAA and have certain signs on brain scans.
This study tests whether the drug LXB (sodium oxybate) can help clear abnormal protein buildup in the brain's small blood vessels (CAA). Participants will take LXB nightly for 8 weeks and have MRIs and spinal taps to measure changes.
This trial tests whether an oral traditional Chinese medicine called Naoxuekang dropping pills, given in addition to standard care, can reduce the long-term disability caused by a brain bleed due to high blood pressure. It may help improve recovery for people who have had a recent brain bleed and show signs of small vessel disease on an MRI.
This trial tests whether giving a drug called tranexamic acid (helps stop bleeding) along with very careful blood pressure lowering can reduce bleeding growth and improve recovery after a brain bleed. It is for people who arrive at the hospital very quickly (within 2 hours) after symptoms start.
This trial tests if the antibiotic minocycline can help people recover after a spontaneous brain bleed (intracerebral hemorrhage). It is for patients who have a moderate-sized bleed and are within 48 hours of symptoms starting.
This trial tests a traditional Chinese medicine (called Angong Niuhuang Wan) for people who have had a bleeding stroke within the last 6 hours. The goal is to see if this medicine helps reduce the damage from the bleed and improves recovery.
Hear when a new Cerebral Amyloid Angiopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.